Newsroom

  • Category

  • By Date

  • Press Release

    17 January 24

    CuraTeQ Biologics’ Trastuzumab Biosimilar receives recommendation for marketing authorization in India

    Read more
  • Press Release

    05 July 23

    CuraTeQ Biologics announces positive Phase-3 results for Trastuzumab biosimilar

    Read more